G-ZRLQ6BTKDY

2025 CEO360 San Diego

About CEO360

A New Model for Life Sciences CEOs

Why CEO360?

CEO360 is a comprehensive peer advisory group program designed specifically for Life Sciences CEOs.
This unique platform brings together 20-25 CEOs on a monthly basis to collaborate, share experiences, and tackle their most challenging business issues in a trusted, confidential environment. These groups are designed to help members make better decisions, solve problems, and grow both personally and professionally.

 

How was CEO360 Launched?

CEO360 was founded in 2022 by John Foley and David H. Crean.  
Both John and David have served as strategic advisors to many Life Science CEO’s in the ecosystem with more than 50 years of advisory support, collectively.  They both recognized at that time several key gaps and issues faced by CEOs and executives in the life sciences ecosystem that were not being met effectively through the use of general business advisors, Boards of Directors, consultants, and educational platforms.  The gaps and issues included leadership isolation as a CEO, enhancing decision-making and introducing diverse perspectives, fostering growth and learning, providing accountability and support, facilitating networking and opportunities, and addressing business challenges specific to a CEOs company.

CEO360 groups aim to provide a unique support structure that is often missing in the traditional business environment.  The goal of CEO360 is to empower leaders to make better decisions, grow personally and professionally, and ultimately drive the success of their organizations.

 

CEO360 Culture – Trust, Performance, and Fun

For a Life Sciences CEO, the journey can be quite  overwhelming, disheartening, and lonely
Scientific,  fundraising, and commercialization challenges cause many CEOs to give up the fight before seeing success. With CEO360, we battle out the issues and celebrate the successes together. 
Below are three CEOs, Ana Moreno, Westbrook Weaver and Lu Yin who won recent pitch contests chosen by peers, VC Investors, trusted advisors and partners. All three have advanced with funding and recognition by the Life Sciences ecosystem for scientific excellence.  All three were forced to wear a “gangster costume” (a stupid hat and cheap necklaces on sale at Party City) plus a nice bottle of wine to commemorate their success. 

Ana Moreno of Navega Therapeutics, Pitch Contest Winner
Lu Yin (Persperion) Westbrook Weaver (Tempo Therapeutics), Foley and Crean

What CEOs Can Expect

Benefits of CEO360

By participating in a CEO360 peer advisory group, Life Science business leaders can tap into a powerful network of support, gain valuable insights, and accelerate their personal and professional development.

Collective Wisdom

Access to a pool of knowledge and experience from fellow business leaders in the same sector plus an opportunity to learn from others’ successes and failures

Accountability

Members hold each other responsible for implementing decisions and achieving goals. Regular check-ins promote follow-through on commitments.

Personal Growth

CEOs enhance their leadership skills through group interactions and shared experiences. They develop better communication and problem-solving abilities.

Objective Feedback

CEOs receive unbiased opinions and constructive criticism from peers who question assumptions. In addition, they gain new perspectives on how to manage their toughest business challenges.

Networking

CEO360 CEOs build valuable relationships with other business leaders with the potential for new partnerships and opportunities.

Clarity and Confidence

CEO360 CEOs find that they are better prepared to handle tough questions before meeting with investors and pharmaceutical firms.

Better Model for CEOs

How Peer Advisory Groups Work

Carter Palmer - Third Element Bio
CEO360 is a moderated peer-to-peer advisory program where 20-25 Life Sciences CEOs meet monthly and collaborate to solve their toughest business issues. 
Contact CEO360
Site Links

© All Rights Reserved • Arrow Up Partners, LLC • 2025